Clinical Trials Browser

Phase 3 × Withdrawn × E7777 fusion protein × Clear all

NCT01355783 2013-11-18

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

Phase 3 Withdrawn

Lymphoma, T-Cell, Peripheral